Inheritance of mutant presenilin 1 genes (PSEN1) encoding presenilin 1 (PS1)variants causes autosomal dominant forms of familial Alzheimer's disease (FAD). We previously reported that ubiquitous expression of FAD-linked PS1 variants in mice impairs environmental enrichment (EE)-induced proliferation and neuronal commitment of adult hippocampal neural progenitor cells (AHNPCs). Notably, the self-renewal and differentiation properties of cultured AHNPCs expressing either human PS1 wild-type or PS1 variants were identical, suggesting that accessory cells within the hippocampal niche expressing PS1 variants may modulate AHNPC phenotypes in vivo. We now report that nontransgenic mouse AHNPCs transduced with retroviruses harboring cDNAs that encode either human PS1 wild-type or FAD-linked PS1 variants show no differences in EEmediated proliferation and neuronal differentiation. Moreover, conditional inactivation of a mutant PS1 transgene in type-1 primary progenitor cells failed to rescue impairments of EE-induced proliferation, survival, or neurogenesis. In contrast, conditional inactivation of the mutant PS1 transgene in excitatory neurons of the mouse forebrain largely rescued the deficits in EE-induced proliferation and survival of AHNPCs, but not their differentiation into mature neuronal phenotypes. These results persuasively argue for a noncell autonomous effect of FAD-linked PS1 mutants on EE-mediated adult hippocampal neurogenesis.
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stem cells | neurodegeneration | aging | dementia A lzheimer's disease (AD), a progressive neurodegenerative disorder, is characterized by the presence of amyloid beta (Aβ) peptides and neurofibrillary tangles. Aβ peptides are derived from larger amyloid precursor protein (APP) by the concerted action of BACE1 and γ-secretase. Presenilin 1 (PS1) is the catalytic component of γ-secretase (1) . Inheritance of mutations in PSEN1 causes disease in the vast majority of pedigrees with earlyonset, autosomal dominant forms of familial Alzheimer's disease (FAD) (2) . The molecular mechanisms by which expression of mutant PS1 causes FAD are not fully understood, but the widely held view is that mutant PS1 enhances the ratio of Aβ42/Aβ40 peptides, leading to nucleation, oligomerization, and neuropathogenicity of Aβ42 peptides (3) . Notwithstanding this important aspect of pathogenesis mediated by FAD-linked PS1 variants, it has now become clear that expression of mutant PS1 polypeptides has more global effects on neuronal function and pathophysiology (for review, see ref. 4) . PS1 is ubiquitously expressed in different cell types of the central nervous system (5) (6) (7) and has been shown to play a role in aspects of neurogenesis both during development and in the adult brain (8, 9) . Earlier studies have examined the impact of FAD-linked PS1 mutants on adult hippocampal neurogenesis (10) (11) (12) , but in all these cases, the transgenes were exclusively expressed in neurons and driven by neuron-specific enolase (NSE) or Thymocyte differentiation antigen 1 promoters. For example, expression of the NSE promoter-driven PSEN1-P117L variant mutant failed to promote neurogenesis under standard housing (SH) conditions (12) and impairs survival of adult hippocampal neural progenitor cells (AHNPCs) and neuronal differentiation under environmental enrichment (EE) conditions (11) . Although of interest, these studies remain silent with respect to other cell types in the hippocampus that impact upon AHNPC phenotypes.
We previously reported that ubiquitous expression of FADlinked PS1 mutant polypeptides in transgenic mice impairs EEmediated AHNPC proliferation and neurogenesis (13) . In the present study, we examine the role of FAD-linked mutant PS1 in the regulation of AHNPC proliferation and neuronal differentiation in in vivo settings. We now report that restricted expression of mutant PS1 in AHNPCs does not impair EE-mediated proliferation and neuronal differentiation and that selective genetic deletion of a mutant PS1 transgene in type-1 primary progenitor cells fails to rescue mutant PS1-mediated impairments on EEinduced proliferation, survival, or neurogenesis. Moreover, selective ablation of a mutant PS1 transgene postnatally in excitatory neurons of the forebrain rescues deficits in mutant PS1-mediated EE-induced AHNPC proliferation and survival, but not the neuronal maturation of these cells. Our results provide conclusive evidence that expression of FAD-linked mutant PS1 impairs EEmediated proliferation and neuronal differentiation of AHNPCs in a noncell autonomous manner.
Results
Retroviral Expression of FAD-Linked PS1 Variants in AHNPCs Does Not Impair EE-Induced Proliferation or Neuronal Differentiation Properties in Vivo. We generated recombinant Moloney murine leukemia virus (MoMLV) retroviral vectors harboring cDNA encoding human wild-type PS1 (RV:hPS1WT) or FAD-linked PS1 variants (RV:PS1ΔE9 or RV:PS1M146L), expressed under a compound CAG promoter, and a second cassette with elongation factor 1α (EF1α) promoter-driven enhanced green fluorescent protein (EGFP) reporter cDNA, for lineage tracing studies (Fig. 1A) . The competence of these retroviruses to drive expression of human PS1 polypeptides was tested in HEK 293 cells (Fig. S1A) . As MoMLV specifically transduces mitotically active cells (14) , we tested the cell-intrinsic effects of ectopically expressed hPS1WT or PS1 variants in dividing AHNPCs in vivo. RV:hPS1WT or RV: PS1 variants were stereotaxically injected into the dentate gyrus (DG) of a cohort of 1-mo-old nontransgenic male mice. After a 1-wk recovery period, animals were provided with SH or exposed to EE conditions for 1 mo and then euthanized to examine the fate of AHNPCs. We chose the 5 wk postinjection time frame because a small, but detectable fraction of retrovirus-infected cells retain expression of nuclear cell proliferation-associated antigen (Ki67) (15, 16) , thereby allowing us to get an estimate on both the pool of proliferating precursors and neuronal lineage committed descendants. Several EGFP-expressing cells were detected at the site of retroviral injection coordinates within the DG (Fig. 1B) . Nuclear staining with DAPI revealed that the transduced, EGFP + cells were located either at the hilar (HL) border of the granule cell layer (GCL) or at the mid-GCL, the latter with spiny dendritic processes that extended to the upper molecular layer (ML) (Fig. 1C) . Consistent with previous studies (16), we also observed that a significant fraction of EGFP + cells exhibited features of mature neurons. Moreover, and in comparison with SH conditions, we observed a significant increase in neurogenesis in mice expressing hPS1WT following EE, as expected, but surprisingly, in mice expressing mutant PS1 variants as well (Fig. 1C, Right) .
To assess the proliferation of EGFP + cells, we stained sections with Ki67 antibodies (Fig. 1D ). These studies revealed that animals expressing RV:hPS1WT and subjected to EE conditions showed a significant increase in the percentage of Ki67 + /EGFP + AHNPCs from 3.25% to 10.3% ( Fig. 1E , P < 0.05 for SH vs. EE hPS1WT). Interestingly, expression of the PS1ΔE9 and PS1M146L variants also showed a prominent increase in EE-induced proliferation of Ki67 + /EGFP + AHNPCs from 3.5% to 9.6% and from 3.8% to 11%, respectively ( Fig. 1E , P < 0.01 for SH vs. EE PS1 variants), with no significant differences compared with animals that expressed the RV:hPS1WT. To determine whether intrahippocampal delivery of retrovirus per se affects AHNPC proliferation, we quantified the total number of Ki67 + cells (Fig. S1B ). In comparison with SH conditions, an overall ∼1.4-fold increase in total Ki67
+ cells was observed in mice expressing hPS1WT or PS1 variants that were exposed to EE conditions (Fig. S1C) .
To investigate whether neuronal lineage differentiation of AHNPCs was affected upon ectopic expression of hPS1WT or PS1 variants, we performed immunostaining with antibodies to the mature neuronal nuclear antigen (NeuN) (Fig. S1D) , or the immature and mature neuronal antigen, prospero homeobox 1 (Prox1) (Fig. S1E) 
/EGFP
+ neurons between animals that expressed hPS1WT or PS1 variants. Collectively, these studies reveal that cell-intrinsic expression of mutant PS1 in AHNPCs does not impair EE-mediated proliferation or neuronal differentiation of these progenitors.
Characterization of Mice Expressing a Mutant PSEN1 Transgene That
Can Be Conditionally Inactivated. To validate the conclusions drawn from the retroviral-mediated AHNPC transduction studies ( Fig. 1 ), we generated a construct, PrP.PS1ΔE9 lox/lox .cGFP, in which the murine prion promoter (PrP) drives expression of a mutant PS1ΔE9 cDNA that is flanked by loxP sites and includes a cDNA placed downstream that encodes a copepod green fluorescent protein (cGFP). The rationale for this design is that the PrP drives ubiquitous expression of the PS1ΔE9 transgene in all neuronal and nonneuronal cell types, leaving expression of the cGFP reporter silent. On the other hand, cell-type-specific expression of cre recombinase results in excision of the PS1ΔE9 cDNA cassette, thus activating expression of the cGFP reporter, and hence serves to score the recombination event ( Fig. 2A) .
As a proof of concept, we transiently transfected parallel dishes of HEK293 cells with the PrP.PS1ΔE9 lox/lox .cGFP trans- gene singly or in combination with a pCMVcre plasmid and assessed cGFP fluorescence. We show that cGFP fluorescence, which reports on successful recombination, appears only in cells cotransfected with the PrP.PS1ΔE9 lox/lox .cGFP and pCMV-Cre plasmids (Fig. S2A) .
We then generated a transgenic mouse line harboring the PrP. PS1ΔE9 lox/lox .cGFP transgene (PS1ΔE9flox mice) and performed Western blot analysis of detergent-solubilized brain lysates. We observed expression of the PS1ΔE9 polypeptide and significant "replacement" of the endogenous N-terminal fragment derivative of mouse PS1 (Fig. S2B, lane2 ), as we had previously described (6) . Immunohistochemical staining of adult brain sections using a human PS1-specific monoclonal antibody revealed expression of human PS1ΔE9 in cells located in the subgranular layer (SGL), the GCL, and the ML of the DG (Fig. S2C) . Notably, we did not observe cGFP expression or fluorescence in total brain lysates or in hippocampal sections (see Fig. 4A ) from PS1ΔE9flox mice.
To establish that expression of the PrP.PS1ΔE9 lox/lox .cGFP transgene leads to deficits in EE-mediated proliferation and neuronal differentiation, as we had previously described for the PrP.PS1ΔE9 mice (13), we exposed cohorts of PS1ΔE9flox, PrP. hPS1WT (hPS1WT), or PrP.PS1ΔE9 (PS1ΔE9) transgenic mice to SH or EE conditions for 1 mo. At the end of 1 mo, animals housed under these two conditions were injected intraperitoneally (i.p.) with a single dose of 100 mg/kg of BrdU. Mice were killed 24 h postinjection, and brain sections were subjected to immunofluoresence analysis using a BrdU-specific antibody (Fig. S2D) , and the number of BrdU-positive cells in the SGL was quantified as previously described (13) . No significant differences in BrdU + cell numbers were observed in the DG of hPS1WT, PS1ΔE9, or PS1ΔE9flox mice that were exposed to SH conditions (Fig. 2B ). In comparison with SH conditions, exposure to EE conditions led to a prominent increase in BrdU + cell numbers in hPS1WT mice, but not in PS1ΔE9 mice, consistent with our earlier findings (13), and more importantly, the PS1ΔE9flox mice also showed a failure to enhance the levels of BrdU + cells in the DG upon EE (Fig. 2B) . In parallel, analysis of the absolute numbers of Ki67 + proliferating cells in the SGL of SH and EE mice (Fig. S2E ) revealed a significant, ∼1.9-fold increase in hPS1WT mice upon EE, but no such increase in PS1ΔE9 or PS1ΔE9flox mice exposed to EE over corresponding groups maintained under SH conditions (Fig. 2C) .
To assess the impact of expressing the FAD-linked mutant PS1ΔE9 on EE-induced differentiation of newly born AHNPCs into neuronal lineages, we exposed a cohort of hPS1WT, PS1ΔE9, or PS1ΔE9flox mice to EE conditions for 1 mo and then injected these animals with a single dose of BrdU (100 mg/kg). Two weeks later, brain sections were subjected to immunofluorescence staining with anti-BrdU antibodies combined with βIII tubulin-specific antibody (Tuj1) to mark both early and mature neurons or with anti-doublecortin (DCX) antibodies to mark early neuronal lineages (Fig. S2F) . We observe that the percentage of newly born BrdU + AHNPCs that differentiated toward neuronal lineages was significantly lower in both PS1ΔE9 and PS1ΔE9flox mice compared with the levels observed in hPS1WT mice (Fig. 2D) . Collectively, these data indicate that EE-mediated enhancement of proliferation and neuronal differentiation of newly born progenitors is attenuated in PS1ΔE9flox mice. We then sought to evaluate whether expression of FAD-linked mutant PS1 expression in PS1ΔE9flox mice affects the proliferation or multilineage differentiation potential of cultured ANHPCs. Primary neurosphere cultures were established from dissected hippocampus of 2-mo-old hPS1WT or PS1ΔE9 as controls and from that of PS1ΔE9flox mice (Fig. S3A) . Western blot analysis of detergentsolubilized neurosphere lysates confirmed the expression of human PS1 polypeptides in AHNPCs (Fig. S3B) . Using an ELISA-based BrdU-uptake assay (13, 17) , we show that the proliferations of AHNPCs cultured from hPS1WT, PS1ΔE9, and PS1ΔE9flox mice are indistinguishable (Fig. S3C) and that the multipotencies of neurospheres derived from each of the three transgenic lines into a neuronal or glial lineage are identical (Fig. S3 D and E) . Parallel BrdU-uptake analyses of subventricular zone (SVZ)-derived NPC cultures reveal that in comparison with NPCs from hPS1WT mice, NPCs from PS1ΔE9flox mice exhibit retarded growth by day 5 (Fig.  S3F) , indicating a cell-intrinsic property of mutant PS1 expression on proliferation, as we had shown earlier for SVZ-derived adult NPCs from PS1ΔE9 mice (17) . Collectively, these studies argue that AHNPCs and SVZ-derived NPCs from PS1ΔE9flox mice exhibit similar proliferation and neuronal differentiation properties to those of neurospheres derived from PS1ΔE9 mice.
Selective Ablation of PS1ΔE9 Expression in Type-1 Primary Progenitors in PS1ΔE9flox Mice. Having established that ubiquitous expression of PS1ΔE9 impairs EE-induced AHNPC proliferation and neuronal commitment in PS1ΔE9flox mice, we asked whether selective excision of the PS1ΔE9 cassette in Nestin-expressing type-1 primary progenitor cells might impact on AHNPC phenotypes that coexist in an otherwise mutant PS1 "neighborhood". To address this question, PS1ΔE9flox mice were crossed with mice homozygous for a tamoxifen (TAM)-inducible, Nestin-CreER T2 (NestinCre) transgene (18) to generate bigenic PS1ΔE9flox/NestinCre mice. Cohorts of these mice were injected i.p. with 180 mg·kg −1 ·d −1 of TAM or vehicle for 5 consecutive days starting at 5-6 wk of age. Fifteen days after the last injection, a second dose of 180 mg·kg −1 ·d −1 of TAM or vehicle was administered for 5 consecutive days. Twenty days after the last injection, we observed that in TAM-treated animals, several cGFP + cells were observed in the upper and lower leaves of the DG (Fig. 3A, i) , of the SGL (Fig. 3A, ii) , and in the SVZ of the lateral ventricle (Fig. S4A) , as expected (18) . No detectable cGFP-expressing cells were observed in the vehicle treatment group (Fig. 3A, iii) .
Morphological evaluation of cGFP + cells revealed a spectrum of cell types: type-1 primary progenitor cells (Fig. 3B, i) , transit amplifying progenitors (TAPs) (Fig. 3B , ii, open arrow), neuroblasts (Fig. 3B, ii, arrowhead) , immature neurons (Fig. 3B, ii, solid arrow) , and mature neurons (Fig. 3B, iii) . To distinctly categorize and confirm the identity of the cGFP + cells that are detected 55 d after the first TAM injection, we performed immunolabeling studies using antibodies to type-1 progenitor marker, sex determining region Y-related homeo-box 2 (Sox2), or GFAP; TAP marker, Ki67; neuroblast marker, DCX; and mature neuronal marker, NeuN 3, 7 (PS1ΔE9); and 5, 8 (PS1ΔE9flox), exposed to SH or EE (m ± SEM). **P < 0.01. (C) Quantification of total Ki67 + cells in SGL. n = 7, 7 (hPS1WT); 9, 9 (PS1ΔE9); and 8, 8 (PS1ΔE9flox), exposed to SH or EE (m ± SEM). **P < 0.01. (D) Quantification of colabeled cells in SGL of the abovementioned transgenic mouse lines exposed to EE. n = 5, 5, and 6 in hPS1WT, PS1ΔE9, and PS1ΔE9flox, respectively (m ± SEM). **P < 0.01, *P < 0.05. (Fig. S4B ). Approximately 13.7 ± 1.2% and 12.9 ± 1.5% of cGFP + cells in the SGL were colabeled with anti-Sox2 or anti-GFAP antibodies, respectively. Totals of 12.5 ± 0.6% of cGFP + cells colabeled with anti-Ki67 antibodies, ∼19.7 ± 1.2% of cGFP + cells colabeled with the anti-DCX antibodies, and 8.9 ± 1.03% of cGFP + cells colabeled with anti-NeuN antibodies. Together, these observations document that TAM-inducible excision of loxP sites with concomitant cGFP reporter expression can be achieved in PS1ΔE9flox/NestinCre mice and that the murine prion promoter is active in adult type-1 primary progenitor cells and in the spectrum of cell types derived from Nestin-expressing type-1 progenitors.
Having established that the TAM-treated bigenic mice exhibit selective cGFP expression in AHNPCs and their progeny, we subjected a cohort of 5-wk-old PS1ΔE9flox/NestinCre mice to TAM injections, as above, and exposed one-half of the animals to either SH or EE conditions for 1 mo, before euthanizing them. We found no significant increase in total Ki67
+ cell numbers in TAM-vs. vehicle-administered PS1ΔE9flox/NestinCre mice exposed to EE, compared with the respective groups maintained under SH conditions (Fig. 3C ). Colabeling analysis of cGFP + cells in the TAM-treated PS1ΔE9 flox/NestinCre mice maintained in SH conditions revealed that only 12.5 ± 0.6% of cGFP + cells were positive with anti-Ki67 antibodies; this value is an underestimate as the TAM treatment was performed for 1 mo, a point at which most cells in which recombination occurred are postmitotic and driven to neuronal lineages. Quantification of the total number of cGFP + /Ki67 + double-positive cells in TAMtreated bigenic mice exposed to SH or EE conditions (Fig. S4C ) revealed a slight, but statistically insignificant decrease in the total number of cGFP + /Ki67 + cells between SH and EE bigenic mice groups (Fig. 3D , 109 ± 15.5 vs. 96 ± 10.2, respectively; P = 0.23). Hence, the presence or absence of PS1ΔE9 expression in type-1 primary or proliferating TAPs has a negligible impact on EE-mediated proliferation of the progenitors.
We then examined neuronal differentiation in the TAMtreated PS1ΔE9flox/NestinCre mice group exposed either to SH or to EE conditions (Fig. S4D) . We observed subtle changes from 232 ± 22.9 to 220 ± 24 of cGFP + /DCX + and from 110 ± 13.5 to 118 ± 11.6 of cGFP + /NeuN + cells in SH vs. EE bigenic mice groups, respectively, but these differences did not achieve statistical significance (Fig. 3D, P ; SH vs. EE). Consistent with these observations, we also failed to observe a significant difference in total cGFP + cells generated between SH and EE groups ( Fig. 3E , P = 0.054, total cGFP + ; SH vs. EE). Hence, in TAM-treated, enriched PS1ΔE9flox/NestinCre mice, we fail to rescue the deficits in AHNPC proliferation and differentiation that are otherwise observed following enrichment of PS1ΔE9flox mice.
AHNPC Phenotypes in PS1ΔE9flox
Mice with Selective Excision of PS1ΔE9 in Forebrain Excitatory Neurons. To examine the impact of deleting the PS1ΔE9flox transgene selectively in excitatory neurons on AHNPC phenotypes, we crossed PS1ΔE9flox mice with CamKIICre transgenic mice (line T29-1) (19), wherein Cre expression occurs postnatally and is restricted to excitatory neurons of the forebrain. In the resultant bigenic PS1ΔE9flox/CamKIICre mice, cGFP signal appeared in forebrain areas, including the cortex and hippocampus at 3 mo of age (Fig. 4 A and B) . In the hippocampus, cGFP is present in hilar mossy fiber axons (Fig. 4C ) and cell bodies in the middle and outermost dentate granule cells and their dendritic trees (Fig. 4D) . To confirm the identity of cGFP + cells, we performed immunolabeling studies using antibodies to Sox2, Ki67, the type-2 progenitor marker antigen, T- brain gene-2 (Tbr2), the early immature neuronal/neuroblast markers polysialylated-neuronal cell adhesion molecule (PSA-NCAM) and DCX, respectively, Prox1, NeuN, S100 calciumbinding protein beta (s100β), and GFAP (Fig. S5) . No cGFP reporter fluorescence was observed in cells that were positive for Sox2, Ki67, or Tbr2, indicating that recombination did not occur in type-1 or proliferating type-2 progenitor cells (Fig. S5A) . On the other hand, a small fraction of cGFP + cells colabeled with the PSA-NCAM (0.18 ± 0.03%) and DCX (0.55 ± 0.08%), respectively (Fig. S5A) . However, a significant fraction of cGFP + cells colabeled with the mature neuronal markers, Prox1 (∼81.09 ± 4.89%) and NeuN (88.24 ± 1.57%), respectively (Fig. S5B) . Supporting the neuronal specific activity of CamKII-gene regulatory sequences (20) , we failed to detect cGFP expression in s100β-or GFAP-labeled cells (Fig. S5B) .
To assess the impact of deleting the PS1ΔE9 lox/lox transgene in excitatory neurons on EE-mediated proliferation and differentiation of AHNPCs, we exposed cohorts of 3-mo-old hPS1WT, PS1ΔE9, or PS1ΔE9flox mice or PS1ΔE9flox/CamKIICre mice to SH or EE conditions for 1 mo. At the end of 1 mo, animals were injected with a single dose of BrdU and killed 24 h later, and AHNPC proliferation was assessed using BrdU-specific antibodies (Fig. S6A) . No significant differences in BrdU + cell numbers were observed in the DG of hPS1WT, PS1ΔE9, or PS1ΔE9flox mice or PS1ΔE9flox/CamKIICre transgenes that were exposed to SH conditions (Fig. 5A) . Furthermore, and as shown earlier (Fig. 2B,  above) , exposure to EE led to a prominent increase in BrdU + cell numbers in hPS1WT mice, but not in PS1ΔE9 or PS1ΔE9flox/ CamKIICre mice. On the other hand, PS1ΔE9flox/CamKIICre mice showed a significant increase in BrdU + cell numbers following exposure to EE-housing conditions (Fig. 5A, 1,350 ± 168.57 SH vs. 2,929.8 ± 443.57 EE, P = 0.02). More importantly, the observed increase in BrdU + cells in enriched bigenic mice approached the levels seen in enriched hPS1WT mice (Fig. 5A, 2 ,929.8 ± 443.57 EE bigenic vs. 3,645.6 ± 500.12 EE hPS1WT, P = 0.22).
To assess whether the remarkable rescue of EE-mediated AHNPC proliferation in PS1ΔE9flox/CamKIICre mice could be extended to the survival of these cells, we exposed 3-mo-old cohorts of hPS1WT, PS1ΔE9flox, PS1ΔE9flox/NestinCre, or PS1ΔE9flox/CamKIICre mice to either SH or EE conditions for 1 mo; injected animals with a single dose of BrdU; and killed them 2 wk later. Quantification of BrdU + cells in the SGL revealed statistically insignificant differences across all genotypes under SH (Fig. 5B) . However, in comparison with respective cohorts exposed to SH, EE housing resulted in a significant increase in the number of BrdU + cells in hPS1WT (764 ± 52.89 SH vs. 1697 ± 85.46 EE, P < 0.001), but not in PS1ΔE9flox or TAM-treated PS1ΔE9flox/NestinCre mice. Interestingly, in comparison with SH, a prominent increase in BrdU + cells was also detected in bigenic PS1ΔE9flox/CamKIICre mice following exposure to EE conditions (598.8 ± 29.23 SH vs. 1,410 ± 140.96 EE, P < 0.01) that was statistically significant with the BrdU + cell numbers observed in enriched hPS1WT mice (1,410 ± 140.96 EE PS1ΔE9flox/ CamKIICre vs. 1,697 ± 85.46 EE hPS1WT, P = 0.0518). Consistent with this observation, the survival ratio, calculated from total BrdU + cell numbers at 2 wk divided by the BrdU + numbers at 24 h post-BrdU injection, showed a comparable increase in survival ratio from 42.44% to 46.54% in hPS1WT and from 44.35% to 48.17% in PS1ΔE9flox/CamKIICre mice under SH or EE conditions, respectively. Together, these data reveal that the deleterious effects of mutant PSEN1 on EE-induced proliferation and survival of newborn progenitors are the largely the result of mutant PS1 expression in excitatory neurons, including granule cell neurons.
To examine whether removal of the mutant PSEN1 transgene in excitatory neurons can rescue the deficits in neuronal differentiation, seen earlier (Fig. 2D) , we performed double-labeling studies using anti-BrdU antibodies combined with neuronal lineagespecific antibodies (Fig. S6B) . Cohorts of hPS1WT, PS1ΔE9flox, or PS1ΔE9flox/CamKIICre mice were exposed to EE conditions for 1 mo beginning at 3 mo of age and then injected with a single dose of 100 mg/kg BrdU and killed 2 wk later. Quantification of BrdU + cells that were colabeled with antibodies to Tbr2, DCX, βIII tubulin, Prox1, or NeuN revealed that in comparison with hPS1WT mice, the numbers of colabeled cells in PS1ΔE9flox mice were significantly lower (Fig. 5C ), a result consistent with our earlier studies performed when animals were exposed to EE conditions beginning at 2 mo of age (Fig. 2D ) and the findings reported for PS1ΔE9 transgenic mice (13 
/Prox1
+ colabeled cell numbers over the levels seen in PS1ΔE9flox mice (Fig.  5C ). However, no significant increases in BrdU + /NeuN + cell numbers were observed in bigenic mice compared with PS1ΔE9flox mice. Interestingly, the observed increase in newborn BrdU + cells expressing early/immature neuronal lineages antigens in bigenic PS1ΔE9flox/CamKIICre mice was significantly reduced compared with the levels detected in hPS1WT mice following exposure to EE. These findings and the observation that BrdU + /NeuN + cell numbers are not elevated in PS1ΔE9flox/CamKIICre mice compared with PS1ΔE9flox mice strongly suggest that cells other than excitatory neurons play a role in mediating aspects of neuronal maturation or differentiation of AHNPCs in PS1ΔE9flox mice following exposure to EE conditions.
Discussion
In preceding efforts, we reported that EE-induced proliferation and neuronal lineage commitment of AHNPCs are severely compromised in transgenic mice that ubiquitously express human PS1 variants that cause FAD (13) . Moreover, the proliferation and neuronal differentiation properties of AHNPCs cultured from mice expressing either hPS1WT or PS1 mutants are indistinguishable (13) . Extending these observations, we also colabeled with the abovementioned stage-specific markers. n = 6 (hPS1WT), 6 (PS1ΔE9flox), and 7 (PS1ΔE9flox/CamKIICre) exposed to EE, except n = 4 per genotype for BrdU + Tbr2 + (m ± SEM). **P < 0.01, *P < 0.05,
reported that conditioned medium of neonatal microglia from mice expressing PS1 variants impairs the proliferation and neuronal lineage commitment of hPS1WT AHNPCs, findings that recapitulated the results observed in vivo (13) . These results lead us to propose that the observed defects in the proliferation and neuronal differentiation of AHNPCs in mice expressing mutant PS1 are due not to cell-intrinsic expression of mutant PS1 within the progenitors, but the result of expression of the PS1 variants in other cells that reside within the hippocampal stem cell niche (13) . Although intriguing, our conclusions relied primarily on observations from in vitro grown AHNPC cultures, and in vivo support for the model remained untested. In the present report, we describe three in vivo strategies to examine cell autonomous vs. noncell autonomous mechanisms by which FAD-linked PS1 variants impair EE-mediated AHNPC proliferation and neuronal differentiation and now offer several important insights. First, we used retroviral delivery to express cDNAs encoding hPS1WT or PS1 variants exclusively in proliferating AHNPCs of wild-type mice and now show that EE-mediated proliferations of AHNPCs expressing wild-type or mutant PS1 are comparable. Moreover, we failed to observe any differences in the percentage of virally transduced cells expressing either hPS1WT or PS1 mutants that exhibited neuronal differentiation markers, including Prox1 or NeuN, following EE. These findings indicate that cell-intrinsic expression of FAD-linked PS1 variants solely in AHNPCs does not compromise EE-mediated neurogenesis. Second, using a unique PS1ΔE9flox transgenic mouse line that expresses a mutant PS1ΔE9 that could be conditionally ablated, we show that selective, inducible deletion of the transgene in Nestin-expressing type-1 primary progenitors and their progeny cell types does not impair EEinduced proliferation and neuronal differentiation of AHNPCs in these mice. The data convincingly demonstrate that selective silencing of the PS1ΔE9 transgene in type-1 progenitor cells and their derivatives does not reverse the impairments in neurogenesis observed in PS1ΔE9flox mice. These findings support our view that expression of mutant PS1 in other cell types within the SGL stem cell microenvironment compromises the proliferation and differentiation of AHNPCs.
Finally, postnatal silencing of PS1ΔE9 transgene expression in excitatory neurons, including dentate granule cells, resulted in significant recovery of EE-induced AHNPC proliferation and survival in PS1ΔE9flox mice. Interestingly, the numbers of Tbr2-positive cells in enriched PS1ΔE9flox/CamKIICre mice are also elevated, indicating that expression of mutant PS1 in mature granule cells or other excitatory neurons in the hippocampus acts in a noncell autonomous manner to regulate intermediate type-2 transit amplifying progenitor phenotypes. On the other hand, we failed to fully rescue the deficits in neuronal lineage commitment of AHNPCs by selective removal of the mutant PS1ΔE9 transgene in excitatory neurons.
The factors and signaling mechanisms by which expression of mutant PS1 in the hippocampal niche regulates the biology of AHNPCs are far from understood. Nevertheless, our finding that CamKIICre-induced excision of the mutant PSEN1 cassette in excitatory neurons postnatally is insufficient to fully restore EEinduced neurogenesis lead us to conclude that expression of mutant PS1 in other inhibitory neuronal subtypes or nonneuronal cells perturbs the function of those cells in a manner that leads to inhibition of terminal neurogenic differentiation of AHNPCs.
In summary, our data provide compelling evidence to support the proposal that the impairments of EE-induced progenitor proliferation or neurogenesis mediated by FAD-linked PS1 variants occur primarily at the level of expression of the mutant PS1ΔE9 transgene not in AHNPCs, but in other cells in the hippocampal niche that also express the PS1ΔE9 variant. To be established is the extent to which other cells within the hippocampal niche impact on the biology of AHNPCs in PS1ΔE9flox mice.
Materials and Methods
An extended section is provided in SI Materials and Methods.
Recombinant Retrovirus. The MoMLV genome-based (21), pCL vector systemderived pCAG-EGFP plasmid was used to generate replication-incompetent retrovirus encoding hPS1WT or FAD-linked PS1 variants.
Animals. Male mice expressing murine prion promoter-driven PS1 transgenes hPS1WT (line S8-4), PS1ΔE9 (line S9), PS1M146L (line S15), and Nestin-CreER T2 (18) or CamKIICre (line T29-1) (19, 22) were maintained in a (C3H/HeJ × C57BL/6J F3) × C57BL/6J n1 background (6, 23) . Generation of the PS1ΔE9flox mouse line and TAM administration protocol are described in SI Materials and Methods. Animal experiments were conducted in accordance with institutional and National Institutes of Health guidelines.
